Business Description
Cipher Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA17253X1050
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | 3.29 | |||||
Interest Coverage | 32.91 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.16 | |||||
Beneish M-Score | -1.78 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 16.4 | |||||
3-Year EPS without NRI Growth Rate | 41.2 | |||||
3-Year FCF Growth Rate | 17.8 | |||||
3-Year Book Growth Rate | 42.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 40.43 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.42 | |||||
9-Day RSI | 59.72 | |||||
14-Day RSI | 55.54 | |||||
6-1 Month Momentum % | 69.83 | |||||
12-1 Month Momentum % | 133.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 235.93 | |||||
Days Sales Outstanding | 102.57 | |||||
Days Payable | 410.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 3.8 | |||||
Shareholder Yield % | -1.76 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.78 | |||||
Operating Margin % | 36.35 | |||||
Net Margin % | 59.74 | |||||
FCF Margin % | 49.66 | |||||
ROE % | 18.33 | |||||
ROA % | 15.29 | |||||
ROIC % | 26.29 | |||||
ROC (Joel Greenblatt) % | 265.45 | |||||
ROCE % | 10.17 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.04 | |||||
Forward PE Ratio | 13.58 | |||||
PE Ratio without NRI | 15.46 | |||||
Shiller PE Ratio | 77.42 | |||||
Price-to-Owner-Earnings | 24.13 | |||||
PEG Ratio | 0.75 | |||||
PS Ratio | 10.1 | |||||
PB Ratio | 2.77 | |||||
Price-to-Free-Cash-Flow | 20.22 | |||||
Price-to-Operating-Cash-Flow | 20.17 | |||||
EV-to-EBIT | 34.21 | |||||
EV-to-EBITDA | 26.54 | |||||
EV-to-Revenue | 12.42 | |||||
EV-to-Forward-Revenue | 6.24 | |||||
EV-to-FCF | 23.41 | |||||
Price-to-Projected-FCF | 1.61 | |||||
Price-to-Median-PS-Value | 3.9 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.18 | |||||
Earnings Yield (Greenblatt) % | 2.93 | |||||
FCF Yield % | 4.42 | |||||
Forward Rate of Return (Yacktman) % | 18.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cipher Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 24.18 | ||
EPS (TTM) (€) | 0.579 | ||
Beta | 0 | ||
Volatility % | 76.99 | ||
14-Day RSI | 55.54 | ||
14-Day ATR (€) | 0.46567 | ||
20-Day SMA (€) | 9.62 | ||
12-1 Month Momentum % | 133.41 | ||
52-Week Range (€) | 3.7 - 12.7 | ||
Shares Outstanding (Mil) | 25.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cipher Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cipher Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cipher Pharmaceuticals Inc Frequently Asked Questions
What is Cipher Pharmaceuticals Inc(STU:PHE)'s stock price today?
When is next earnings date of Cipher Pharmaceuticals Inc(STU:PHE)?
Does Cipher Pharmaceuticals Inc(STU:PHE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |